ESSENTIAL HYPERTENSION
Clinical trials for ESSENTIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for ESSENTIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Five new shots at taming high blood pressure
Disease control Not yet recruitingThis study aims to find the best dose of a new drug, called BR1400, to lower high blood pressure. It will involve 330 adults with high blood pressure who will try one of five different doses or a placebo for 8 weeks. The main goal is to see how much each dose lowers blood pressur…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Can you reverse high blood pressure? new trial tests Drug-Free remission
Disease control Not yet recruitingThis study is testing if a structured program can put high blood pressure into remission, allowing people to safely stop their medication. It will enroll 240 adults with stable high blood pressure. The program combines a 12-week intensive lifestyle plan with a careful, step-by-st…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: NA • Sponsor: Evelyn Vanina Re • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists test new combo pill for high blood pressure
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how the body absorbs and processes two common blood pressure medications, fimasartan and indapamide. It will compare taking them as separate pills versus a single combined pill. The study involves 48 healthy volunteers and focuses on safe…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
First human test for new blood pressure pill combo
Knowledge-focused Not yet recruitingThis is an early safety study to see how the body absorbs and processes two common blood pressure medications—fimasartan and indapamide—when given as separate pills versus a single combined pill. It will involve 58 healthy adult volunteers who will take the drugs on an empty stom…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test how new blood pressure combo works in body
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how the body processes two blood pressure drugs, given separately and together, in healthy volunteers. It will measure drug levels in the blood and check for safety. The goal is to gather basic information to help design future studies fo…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
Scientists test how body handles new blood pressure combo pill
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how the body processes and tolerates a new combination pill for high blood pressure. It will involve 48 healthy adult volunteers who will take the pill after a meal. The main goal is to measure the drug levels in the blood and check for s…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC